PATENT CLAIM ANALYSIS

Application Number: 15922810
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "133100"]

Abstract:
Disclosed herein are antibodies which specifically bind to at least one epitope defined by the immunogenic glycopeptide. Other aspects of the present disclosure are pharmaceutical composition comprising the antibody; and method for preventing and/or treating Globo-H-positive cancer.

Claim (Index 9):
The antibody or an antigen-binding portion thereof of  claim 6  comprising\n (i) a heavy chain variable region comprising an amino acid sequence consisting of SEQ ID NO: 147, and \n (ii) a light chain variable region comprising an amino acid sequence consisting of SEQ ID NO: 195.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15126945', '15655105', '15683685', '15303132', '15288562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6033941481562389
- 35 USC 102 Novelty (BERT): 0.6905231731124444
- Combined Prediction Score: 0.6121070506518594
- Mean Citation Score: 509.547168
- Max Citation Score: 903.6957
- Similarity Product: 666.5959765936376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test